2022-11-15
2022-12-11
2022-11-25
2022-11-17
2022-11-22
2022-11-21
2022-11-15
2022-11-21
2022-12-28
辉大基因首款基因治疗药物HG004获美国FDA孤儿药资格认定
2023-04-03
2023-09-27
“基因编辑第一股”百奥赛图启动科创板IPO辅导,布局抗体药物开发全产业链
2023-01-03
2022-11-26
2023-02-23
Science子刊:基因编辑+基因工程干细胞疗法,增强脑转移肿瘤免疫治疗
2023-06-06
2023-02-17